Related Experiment Video
Updated: Jul 15, 2026

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
Acute heart failure after myocardial infarction
Amra Macić-Dzanković1, Belma Pojskić
1Department of Cardiology, General Hospital Dr. A. Nakas, Kranjcevićeva 12, 71 000 Sarajevo, Bosnia and Herzegovina.
Insights
Early fibrinolytic therapy for acute myocardial infarction significantly preserves heart muscle and improves pump function. Prompt treatment within six hours offers substantial benefits over later anticoagulant-only approaches.
Area of Science:
- Cardiology
- Emergency Medicine
Background:
- Acute myocardial infarction (AMI) requires timely intervention to minimize cardiac damage.
- Treatment strategies vary based on patient presentation and time to hospitalization.
Purpose of the Study:
- To compare the efficacy of fibrinolytic therapy versus anticoagulant therapy in patients with acute myocardial infarction.
- To evaluate the impact of treatment timing on myocardial muscle mass and pump function.
Main Methods:
- Two patient groups were compared: those receiving fibrinolytics within six hours of symptom onset and those treated with anticoagulants only.
- Patients were classified using Killip classification, shock index, and TIMI risk score.
Main Results:
- Fibrinolytic therapy administered within the optimal time window (≤6 hours) demonstrated significant benefits.
- Early fibrinolysis was associated with better preservation of myocardial muscle mass.
- Improved myocardial pump function was observed in the group receiving timely fibrinolytic treatment.
Conclusions:
- Fibrinolytic therapy is highly effective when administered promptly after the onset of acute myocardial infarction symptoms.
- Timely intervention is crucial for preserving cardiac function and myocardial viability.
- Anticoagulant therapy alone is less effective for maintaining myocardial muscle mass and pump function in AMI patients presenting outside the optimal treatment window.
Abstract:
We compared two groups of patients after acute myocardial infarction. First group was treated with fibrinolytics and they were hospitalized within six hours from the beginning of the first chest-symptoms, and second group that did not come within optimal time was treated with anticoagulants only. The patients were classified according to Killip-classification, shock-index and TIMI-risk-score after myocardial infarction. Results prove great benefit of fibrinolytic therapy in optimal time, concerning both keeping myocardial muscle mass and myocardial pump function.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure V: Medical Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure VII: Nursing Interventions

